{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:23:03Z","timestamp":1790230983557,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.coph.2025.102574","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:10:44Z","timestamp":1758067844000},"page":"102574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ivermectin and non-parasitic disorders: An update"],"prefix":"10.1016","volume":"85","author":[{"given":"Behdad","family":"Seyyedabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Babataheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziyeh","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Laher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-230X","authenticated-orcid":false,"given":"Hamid","family":"Soraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2025.102574_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/all.13118","article-title":"Topical ivermectin improves allergic skin inflammation","volume":"72","author":"Ventre","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2025.102574_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-020-02612-z","article-title":"Mechanisms of ivermectin-induced wound healing","volume":"16","author":"Sia","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.coph.2025.102574_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00011-008-8007-8","article-title":"Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice","volume":"57","author":"Zhang","year":"2008","journal-title":"Inflamm Res"},{"key":"10.1016\/j.coph.2025.102574_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00011-011-0307-8","article-title":"Anti-inflammatory effects of ivermectin in mouse model of allergic asthma","volume":"60","author":"Yan","year":"2011","journal-title":"Inflamm Res"},{"key":"10.1016\/j.coph.2025.102574_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2016.10.064","article-title":"Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress","volume":"480","author":"Liu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2025.102574_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/fvl-2020-0342","article-title":"Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach","volume":"16","author":"Choudhury","year":"2021","journal-title":"Future Virol"},{"key":"10.1016\/j.coph.2025.102574_bib7","doi-asserted-by":"crossref","first-page":"15773","DOI":"10.1073\/pnas.1520952112","article-title":"2015 nobel laureates in physiology or medicine","volume":"112","author":"Van Voorhis","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2025.102574_bib8","first-page":"CD007745","article-title":"Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection","volume":"2016","author":"Henriquez-Camacho","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2025.102574_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ja.2017.11","article-title":"Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations","volume":"70","author":"Crump","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.coph.2025.102574_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.33549\/physiolres.932711","article-title":"Allosteric modulation of ligand gated ion channels by ivermectin","volume":"63","author":"Zemkova","year":"2014","journal-title":"Physiol Res"},{"key":"10.1016\/j.coph.2025.102574_bib11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.str.2017.04.007","article-title":"Crystal structures of human GlyR\u03b13 bound to ivermectin","volume":"25","author":"Huang","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.coph.2025.102574_bib12","doi-asserted-by":"crossref","first-page":"12556","DOI":"10.1074\/jbc.M011264200","article-title":"Ivermectin, an unconventional agonist of the glycine receptor chloride channel","volume":"276","author":"Shan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2025.102574_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(00)00164-3","article-title":"Activation of rat recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptor by the insecticide ivermectin","volume":"394","author":"Adelsberger","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2025.102574_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.2012.01987.x","article-title":"Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors","volume":"167","author":"N\u00f6renberg","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2025.102574_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.LAB.0000053917.46614.12","article-title":"Central role of fibroblast alpha3 nicotinic acetylcholine receptor in mediating cutaneous effects of nicotine","volume":"83","author":"Arredondo","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.coph.2025.102574_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbagen.2006.09.017","article-title":"GABA-synthesizing enzyme, GAD67, from dermal fibroblasts: evidence for a new skin function","volume":"1770","author":"Ito","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coph.2025.102574_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612936","article-title":"P2X7 receptor regulates collagen expression in human intestinal fibroblasts: relevance in intestinal fibrosis","volume":"24","author":"Lis-L\u00f3pez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2025.102574_bib18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00436-008-0915-6","article-title":"Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep","volume":"102","author":"El-Banna","year":"2008","journal-title":"Parasitol Res"},{"key":"10.1016\/j.coph.2025.102574_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.vetpar.2005.10.002","article-title":"Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs","volume":"135","author":"Gokbulut","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.coph.2025.102574_bib20","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00204-021-03025-z","article-title":"Metabolism and interactions of ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects","volume":"95","author":"Rendic","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.coph.2025.102574_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009354","article-title":"Serious adverse reactions associated with ivermectin: a systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World","volume":"15","author":"Campillo","year":"2021","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.coph.2025.102574_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4269\/ajtmh.17-0042","article-title":"Serious neurological adverse events after ivermectin\u2014do they occur beyond the indication of onchocerciasis?","volume":"98","author":"Chandler","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coph.2025.102574_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkz524","article-title":"Safety of high-dose ivermectin: a systematic review and meta-analysis","volume":"75","author":"Navarro","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coph.2025.102574_bib24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2174\/138920112800399077","article-title":"Macrocyclic lactone anthelmintics: spectrum of activity and mechanism of action","volume":"13","author":"Geary","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"issue":"Suppl 1","key":"10.1016\/j.coph.2025.102574_bib25","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1475-2883-2-S1-S8","article-title":"Ivermectin: does P-glycoprotein play a role in neurotoxicity?","volume":"24","author":"Edwards","year":"2003","journal-title":"Filaria J"},{"key":"10.1016\/j.coph.2025.102574_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcma.2017.11.002","article-title":"Wound healing","volume":"81","author":"Wang","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.coph.2025.102574_bib27","first-page":"1063","article-title":"Topical ivermectin is associated with improved erythematotelangiectatic, papulopustular, and phymatous rosacea in a secondary analysis","volume":"22","author":"Singh","year":"2023","journal-title":"J Drugs Dermatol JDD"},{"key":"10.1016\/j.coph.2025.102574_bib28","doi-asserted-by":"crossref","first-page":"12392","DOI":"10.1021\/acsomega.8b01451","article-title":"Ivermectin promotes peripheral nerve regeneration during wound healing","volume":"3","author":"Cairns","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.coph.2025.102574_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41467-017-01488-2","article-title":"Injury-activated glial cells promote wound healing of the adult skin in mice","volume":"9","author":"Parfejevs","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2025.102574_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13054-021-03862-5","article-title":"Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review","volume":"26","author":"Barichello","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.coph.2025.102574_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cytogfr.2024.10.001","article-title":"The Yin and Yang of TLR4 in COVID-19","volume":"82","author":"Mukherjee","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.coph.2025.102574_bib32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jmv.27405","article-title":"Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19","volume":"94","author":"Manik","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.coph.2025.102574_sref33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112073","article-title":"Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-\u03baB\/p65","volume":"133","author":"Gao","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2025.102574_sref34","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s11011-023-01290-8","article-title":"Neuroprotective effects of ivermectin against transient cerebral ischemia-reperfusion in rats","volume":"38","author":"Seyyedabadi","year":"2023","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.coph.2025.102574_sref35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08923973.2023.2298895","article-title":"Ivermectin ameliorates bleomycin-induced lung fibrosis in male rats by inhibiting the inflammation and oxidative stress","volume":"46","author":"Habibi Razi","year":"2024","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.coph.2025.102574_bib36","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1096\/fj.201903287R","article-title":"P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling","volume":"34","author":"Han","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2025.102574_bib37","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.3390\/ijms21228572","article-title":"P2Y(2) and P2X4 receptors mediate Ca(2+) mobilization in DH82 canine macrophage cells","volume":"21","author":"Sophocleous","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"10.1016\/j.coph.2025.102574_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13223-018-0279-0","article-title":"Asthma","volume":"14","author":"Quirt","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.coph.2025.102574_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108551","article-title":"Biologics for severe asthma and beyond","volume":"252","author":"M\u00fcmmler","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2025.102574_bib40","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.21037\/jtd-24-1751","article-title":"Deficiency of Toll-like receptor 4 attenuates airway inflammation and remodeling in an ovalbumine-induced mouse asthma model","volume":"17","author":"Hou","year":"2025","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.coph.2025.102574_bib41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/lungindia.lungindia_493_19","article-title":"Exploring the effect of presence and type of allergen sensitization on fractional exhaled nitric oxide, immunoglobulin E, and interleukins 4, 5, and 13 among asthmatics","volume":"37","author":"Malhotra","year":"2020","journal-title":"Lung India"},{"key":"10.1016\/j.coph.2025.102574_bib42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WOX.0b013e31821188e0","article-title":"Interleukin-13 signaling and its role in asthma","volume":"4","author":"Rael","year":"2011","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.coph.2025.102574_bib43","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2019.01514","article-title":"Interleukin-5 in the pathophysiology of severe asthma","volume":"10","author":"Pelaia","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.coph.2025.102574_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0163-7258(02)00220-6","article-title":"Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease","volume":"94","author":"Foster","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2025.102574_bib45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.intimp.2008.12.016","article-title":"Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages","volume":"9","author":"Zhang","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2025.102574_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/srep16222","article-title":"Modulation of P2X4\/P2X7\/Pannexin-1 sensitivity to extracellular ATP via ivermectin induces a non-apoptotic and inflammatory form of cancer cell death","volume":"5","author":"Draganov","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2025.102574_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13238-012-2118-2","article-title":"Regulation of HMGB1 release by inflammasomes","volume":"4","author":"Lu","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.coph.2025.102574_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/DDDT.S237393","article-title":"Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin","author":"Liu","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.coph.2025.102574_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2016.06.015","article-title":"Ivermectin exhibits potent anti-mitotic activity","volume":"226","author":"Ashraf","year":"2016","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.coph.2025.102574_bib50","first-page":"3397","article-title":"Ivermectin as an inhibitor of cancer stem-like cells","volume":"17","author":"Dominguez-Gomez","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.coph.2025.102574_bib51","first-page":"317","article-title":"The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug","volume":"8","author":"Juarez","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.coph.2025.102574_sref52","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1186\/s12885-021-09021-x","article-title":"Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.coph.2025.102574_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14235\/bas.galenos.2022.54254","article-title":"Ivermectin induces oxidative stress and DNA damage in breast cancer cells","volume":"11","author":"G\u00fcler","year":"2023","journal-title":"Bezmialem Sci"},{"key":"10.1016\/j.coph.2025.102574_bib54","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1080\/15548627.2016.1231494","article-title":"Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer","volume":"12","author":"Wang","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.coph.2025.102574_sref55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00280-023-04589-6","article-title":"Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells","volume":"93","author":"Li","year":"2024","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.coph.2025.102574_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/0118715206274095231106042833","article-title":"Ivermectin inhibits bladder cancer cell growth and induces oxidative stress and DNA damage","volume":"24","author":"Fan","year":"2024","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.coph.2025.102574_bib57","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192489","article-title":"Ivermectin induces autophagy-mediated cell death through the AKT\/mTOR signaling pathway in glioma cells","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.coph.2025.102574_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-019-1251-7","article-title":"Ivermectin reverses the drug resistance in cancer cells through EGFR\/ERK\/Akt\/NF-\u03baB pathway","volume":"38","author":"Jiang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.coph.2025.102574_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/diseases11010049","article-title":"Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells","volume":"11","author":"Jawad","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.coph.2025.102574_bib60","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1111\/jcmm.15195","article-title":"Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma","volume":"24","author":"Chen","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.coph.2025.102574_bib61","first-page":"10","article-title":"Tsitostaticheskoe i tsitotoksicheskoe de\u012dstvie avermektinov na opukholevye kletki in vitro [Cytotoxic and cytostatic effect of avermectines on tumor cells in vitro]","volume":"45","author":"Mosin","year":"2000","journal-title":"Antibiot Khimioter"},{"key":"10.1016\/j.coph.2025.102574_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13167-020-00209-y","article-title":"Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes","volume":"11","author":"Li","year":"2020","journal-title":"EPMA J"},{"key":"10.1016\/j.coph.2025.102574_bib63","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/antiox11050908","article-title":"Ivermectin-induced apoptotic cell death in human SH-SY5Y cells involves the activation of oxidative stress and mitochondrial pathway and Akt\/mTOR-pathway-mediated autophagy","volume":"11","author":"Zhang","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.coph.2025.102574_sref64","article-title":"Ivermectin has new application in inhibiting colorectal cancer cell growth","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2025.102574_bib65","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jcb.27490","article-title":"Suppressing ROS-TFE3-dependent autophagy enhances ivermectin-induced apoptosis in human melanoma cells","volume":"120","author":"Deng","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.coph.2025.102574_bib66","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.15252\/emmm.201404084","article-title":"The river blindness drug I vermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer","volume":"6","author":"Melotti","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.coph.2025.102574_bib67","first-page":"41","article-title":"Ivermectin concentrations in serum and cerebrospinal fluid after intravenous administration to healthy llamas","volume":"2","author":"Amstel","year":"2019","journal-title":"J Camelid Sci"},{"key":"10.1016\/j.coph.2025.102574_bib68","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11259-007-0050-3","article-title":"The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine","volume":"31","author":"Trailovi\u0107","year":"2007","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.coph.2025.102574_sref69","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1007\/s12035-024-04061-3","article-title":"Ivermectin exerts anticonvulsant effects against status epilepticus induced by lithium-pilocarpine in rats via GABAA receptor and neuroinflammation modulation: possible interaction of opioidergic pathways and KATP channel with nitrergic system","volume":"61","author":"Manavi","year":"2024","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.coph.2025.102574_bib70","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13578-024-01228-2","article-title":"Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function","volume":"14","author":"Wadsworth","year":"2024","journal-title":"Cell Biosci"},{"key":"10.1016\/j.coph.2025.102574_bib71","first-page":"1272","article-title":"Synthesis and evaluation of the effects of solid lipid nanoparticles of ivermectin and ivermectin on cuprizone-induced demyelination via targeting the TRPA1\/NF-kB\/GFAP signaling pathway","volume":"26","author":"Noori","year":"2023","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.coph.2025.102574_sref72","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/epi.17511","article-title":"Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy?","volume":"64","author":"L\u00f6scher","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2025.102574_bib73","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.intimp.2012.10.014","article-title":"Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: are AMPK and TLRs connected?","volume":"14","author":"Soraya","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coph.2025.102574_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7346699","article-title":"Role of AMPK in myocardial ischemia-reperfusion injury-induced ceii death in the presence and absence of diabetes","volume":"2022","author":"Kandula","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.coph.2025.102574_sref75","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11011-025-01657-z","article-title":"Ivermectin's neuroprotective effects decrease with prolonged use after cerebral ischemia\/reperfusion","volume":"40","author":"Rezaei","year":"2025","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.coph.2025.102574_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17582024.2025.2554374","article-title":"Neuroprotective effects of ivermectin on Alzheimer's model induced by streptozotocin in rats","volume":"29","author":"Farajpour","year":"2025","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.coph.2025.102574_sref77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000534206","article-title":"The detrimental effect of pre-treatment with ivermectin on myocardial ischemia","volume":"109","author":"Cheraghi","year":"2024","journal-title":"Pharmacology"},{"key":"10.1016\/j.coph.2025.102574_bib78","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2131\/jts.48.645","article-title":"Cardiovascular safety pharmacology of ivermectin assessed using the isoflurane-anesthetized beagle dogs: ICH S7B follow-up study","volume":"48","author":"Suzuki","year":"2023","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.coph.2025.102574_bib79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ebiom.2017.09.022","article-title":"Antihypertrophic effects of small molecules that maintain mitochondrial ATP levels under hypoxia","volume":"24","author":"Nagai","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2025.102574_bib80","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ymthe.2024.03.018","article-title":"Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing hearts","volume":"32","author":"Xie","year":"2024","journal-title":"Mol Ther"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:48:58Z","timestamp":1763758138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489225000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"alternative-id":["S1471489225000700"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2025.102574","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivermectin and non-parasitic disorders: An update","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2025.102574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102574"}}